Long term haemodynamic, pulmonary function and symptomatic effects of pirbuterol in COPD.

Abstract:

:Haemodynamic studies at rest and during exercise together with radionuclide ventriculography, pulmonary function and clinical well-being assessment were evaluated in ten patients with COPD and secondary pulmonary hypertension (mean PAP 25 mm Hg), before and after 6 months therapy with pirbuterol 20 mg thrice daily. Despite the continued pharmacological action of pirbuterol on the heart and systemic circulation during peak pirbuterol levels at 6 months, no significant effect on the pulmonary circulation was observed. Seven patients reported an improvement in the level of fatigue, the partial pressure of carbon dioxide fell significantly (6.5 +/- 0.9 to 6.1 +/- 0.9 kPa: P less than 0.01) and there was a slight bronchodilator effect [forced expiratory volume in 1s (FEV1) 0.60 +/- 0.18 to 0.71 +/- 0.2 1s-1: P less than 0.02] after 6 months. The drug was generally well tolerated but three patients with pre-existing biliary tract disease developed obstructive jaundice.

journal_name

Respir Med

journal_title

Respiratory medicine

authors

Neilly JB,Carter R,Tweddel A,Martin W,Hutton I,Banham SW,Stevenson RD

doi

10.1016/s0954-6111(89)80061-7

subject

Has Abstract

pub_date

1989-01-01 00:00:00

pages

59-65

issue

1

eissn

0954-6111

issn

1532-3064

pii

S0954-6111(89)80061-7

journal_volume

83

pub_type

临床试验,杂志文章
  • Physiological response to intrapulmonary percussive ventilation in stable COPD patients.

    abstract::Intrapulmonary percussive ventilation (IPV) is a ventilatory technique that delivers bursts of high-flow respiratory gas into the lung at high rates, intended for treating acute respiratory failure and for mobilization of secretions. We performed a study, aimed at assessing the physiological response to IPV, on patien...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.rmed.2006.01.010

    authors: Nava S,Barbarito N,Piaggi G,De Mattia E,Cirio S

    更新日期:2006-09-01 00:00:00

  • Adverse event and treatment completion rates of a 12-dose weekly isoniazid and rifapentine course for South Korean healthcare workers.

    abstract:PURPOSE:We investigated the adverse events (AEs) and treatment completion rates of a 3 month course of once-weekly isoniazid and rifapentine (3H1P1) in South Korean health care workers (HCWs) with latent tuberculosis infection (LTBI). METHODS:HCWs who were candidates for LTBI treatment were enrolled from two tertiary ...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2019.10.005

    authors: Jo KW,Kim JS,Kwon HS,Park YE,Kim JY,Hong MJ,Shim TS

    更新日期:2019-01-01 00:00:00

  • Long-term use of Viozan (sibenadet HCl) in patients with chronic obstructive pulmonary disease: results of a 1-year study.

    abstract::Viozan (sibenadet HCl, AR-C68397AA) is a novel dual D2 dopamine receptor, beta2-adrenoceptor agonist that has been investigated for efficacy in alleviating the symptoms of chronic obstructive pulmonary disease (COPD). The slowly progressive nature of this disease means that patients will require ongoing therapeutic ma...

    journal_title:Respiratory medicine

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Hiller FC,Alderfer V,Goldman M

    更新日期:2003-01-01 00:00:00

  • Modulite technology: pharmacodynamic and pharmacokinetic implications.

    abstract::In the drive to replace chlorofluorinated hydrocarbons (CFCs) by alternative more environmentally friendly propellants in pressurized metered dose inhalers (pMDIs), Chiesi has developed new inhalers using Modulite technology. The aim was to obtain CFC-free pMDIs which are equivalent, in terms of safety and efficacy, t...

    journal_title:Respiratory medicine

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0954-6111(02)80019-1

    authors: Woodcock A,Acerbi D,Poli G

    更新日期:2002-08-01 00:00:00

  • The association between exhaled nitric oxide and sleep apnea: the role of BMI.

    abstract:BACKGROUND:Obstructive sleep apnea syndrome is associated with airway inflammation. Measurement of exhaled nitric oxide is a non-invasive method for evaluation of airway diseases. It seems that obesity is an exacerbating factor for airway inflammation. We aimed to evaluate the changes of exhaled nitric oxide after slee...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2014.05.010

    authors: JalilMirmohammadi S,Mehrparvar AH,Safaei S,Samimi E,Torab Jahromi M

    更新日期:2014-08-01 00:00:00

  • Effect of budesonide/formoterol pMDI on COPD exacerbations: a double-blind, randomized study.

    abstract:BACKGROUND:Treatment with an inhaled corticosteroid (ICS) and long-acting bronchodilator is recommended for severe/very severe chronic obstructive pulmonary disease (COPD) patients with repeated exacerbations. This randomized, double-blind, double-dummy, parallel-group, 12-month multicenter study evaluated the effect o...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.rmed.2011.07.020

    authors: Sharafkhaneh A,Southard JG,Goldman M,Uryniak T,Martin UJ

    更新日期:2012-02-01 00:00:00

  • Short-term effects of nCPAP on nasal mucociliary clearance and mucus transportability in healthy subjects.

    abstract::Nasal mucociliary clearance is a primary defense mechanism of the upper airways and may be acutely affected by nasal continuous positive airway pressure (nCPAP). nCPAP treatment is effective and safe. However, it can cause nasal side effects and contribute to a low compliance to the treatment. The aim of this study wa...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2005.03.042

    authors: de Oliveira LR,Albertini Yagi CS,Figueiredo AC,Saldiva PH,Lorenzi-Filho G

    更新日期:2006-01-01 00:00:00

  • The role of microRNAs in chronic pseudomonas lung infection in Cystic fibrosis.

    abstract:BACKGROUND:Cystic Fibrosis (CF) is the most common life limiting genetic disorder, characterized by chronic respiratory failure secondary to inflammation and chronic bacterial lung infection. Pseudomonas aeruginosa lung infection is associated with more severe lung disease and rapid progression of respiratory failure w...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2019.04.012

    authors: Fesen K,Silveyra P,Fuentes N,Nicoleau M,Rivera L,Kitch D,Graff GR,Siddaiah R

    更新日期:2019-05-01 00:00:00

  • Do current treatment protocols adequately prevent airway remodeling in children with mild intermittent asthma?

    abstract:BACKGROUND:Asthma treatment per Global Initiative for Asthma (GINA) guidelines targets airway remodeling and achievement of normal lung function. OBJECTIVE:To study inhaled steroid therapy on airway remodeling and achievement of normal lung function. SUBJECTS AND SET UP: Asthmatic patients were followed over 5 years ....

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2005.06.011

    authors: Bibi HS,Feigenbaum D,Hessen M,Shoseyov D

    更新日期:2006-03-01 00:00:00

  • Interstitial lung disease and myositis-specific and associated autoantibodies: Clinical manifestations, survival and the performance of the new ATS/ERS criteria for interstitial pneumonia with autoimmune features (IPAF).

    abstract:OBJECTIVE:to describe the clinical manifestations and survival of patients with ILD and myositis-specific and associated autoantibodies, and to evaluate the performance of the new ATS/ERS classification criteria for IPAF. PATIENTS AND METHODS:Patients with ILD and positive in at least one of the following autoantibodi...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2016.12.014

    authors: Mejía M,Herrera-Bringas D,Pérez-Román DI,Rivero H,Mateos-Toledo H,Castorena-García P,Figueroa JE,Rojas-Serrano J

    更新日期:2017-02-01 00:00:00

  • Economic evaluation studies in respiratory medicine.

    abstract::The need for efficient use of resources in the provision of health care is now an accepted reality. Despite its economic significance, respiratory disease has been the subject of very few examples of the application of techniques of economic evaluation. There are a number of examples of cost-minimization studies, and ...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/s0954-6111(06)80169-1

    authors: Buxton MJ

    更新日期:1991-09-01 00:00:00

  • An economic analysis of pharmacological treatment of COPD in Spain.

    abstract:BACKGROUND:COPD is a prevalent disease that generates high use of resources. The objective of this study was to quantify the economic consequences of non-adherence to GOLD guidelines for the management of COPD patients. METHOD:An economic model was generated to compare different scenarios of observed vs. expected cost...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2008.11.019

    authors: Miravitlles M,Brosa M,Velasco M,Crespo C,Gobartt E,Diaz S,González-Rojas N

    更新日期:2009-05-01 00:00:00

  • Bronchial platelet-activating factor receptor in chronic obstructive pulmonary disease.

    abstract:BACKGROUND:Bacteria expressing phosphorylcholine (ChoP) co-opt host-expressed platelet-activating factor receptor (PAFR) to adhere to lower airway cells. Cigarette smoke and rhinovirus (RV) infection upregulate PAFR-dependent bacterial adhesion to airway cells in vitro, and in healthy adults smoking increases the propo...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2014.03.003

    authors: Suri R,Mallia P,Martin JE,Footitt J,Zhu J,Trujillo-Torralbo MB,Johnston SL,Grigg J

    更新日期:2014-06-01 00:00:00

  • What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment?

    abstract::Continuous positive airway pressure (CPAP) is the treatment of choice for obstructive sleep apnoea syndrome (OSAS), but many patients find this treatment intolerable. The aim of this study was to characterize patients who were unable to tolerate CPAP treatment (non-complaint) as opposed to those who continued using CP...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1053/rmed.1999.0703

    authors: Janson C,Nöges E,Svedberg-Randt S,Lindberg E

    更新日期:2000-02-01 00:00:00

  • T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.

    abstract:RATIONALE:Mounting data suggest that immune cell abnormalities participate in the pathogenesis of pulmonary arterial hypertension (PAH). OBJECTIVE:To determine whether the T lymphocyte subset composition in the systemic circulation and peripheral lung is altered in PAH. METHODS:Flow cytometric analyses were performed...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2009.10.004

    authors: Austin ED,Rock MT,Mosse CA,Vnencak-Jones CL,Yoder SM,Robbins IM,Loyd JE,Meyrick BO

    更新日期:2010-03-01 00:00:00

  • Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale.

    abstract::Long-acting bronchodilators in combination with inhaled corticosteroids (ICS) are recommended to decrease the risk of recurrent exacerbations in patients with Global initiative for chronic Obstructive Lung Disease (GOLD) stage 3-4 chronic obstructive pulmonary disease (COPD). There is increasing concern about the clin...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.rmed.2014.01.002

    authors: Magnussen H,Watz H,Kirsten A,Decramer M,Dahl R,Calverley PM,Towse L,Finnigan H,Tetzlaff K,Disse B

    更新日期:2014-04-01 00:00:00

  • Identification of individuals with alpha-1-antitrypsin deficiency by a targeted screening program.

    abstract:BACKGROUND:Alpha-1-antitrypsin deficiency (AATD) is significantly underdiagnosed. The early detection of AATD would enable affected persons to make lifestyle changes such as quitting smoking. It was the aim of the study to determine whether the combination of an awareness program with the offer of a cost-free diagnosti...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2007.02.024

    authors: Bals R,Koczulla R,Kotke V,Andress J,Blackert K,Vogelmeier C

    更新日期:2007-08-01 00:00:00

  • Defective efferocytosis by alveolar macrophages in IPF patients.

    abstract:RATIONALE:Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia. The pathogenicity of IPF has been widely investigated but still remains to be clarified. Efferocytosis, the specialized recognition and ingestion of apoptotic cells by phagocytes, is essential for the resolution of...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2012.08.020

    authors: Morimoto K,Janssen WJ,Terada M

    更新日期:2012-12-01 00:00:00

  • Exhaled nitric oxide and exercise tolerance in severe COPD patients.

    abstract::To answer the question as to whether pulmonary rehabilitation programs (PRP) induced increase in exercise tolerance (ET) is associated with increased levels of exhaled nitric oxide (eNO) in COPD patients of different degrees of severity, we designed a prospective and controlled study. Forty-seven stable COPD patients ...

    journal_title:Respiratory medicine

    pub_type: 临床试验,杂志文章

    doi:10.1053/rmed.2001.1286

    authors: Clini E,Bianchi L,Foglio K,Vitacca M,Ambrosino N

    更新日期:2002-05-01 00:00:00

  • Is inhalation rate important for a dry powder inhaler? Using the In-Check Dial to identify these rates.

    abstract::The fraction of the emitted dose from an inhaler that has the potential to be deposited into the lungs is known as the fine particle dose (also the respirable dose). During inhalation all dry powder inhalers require a 'force' to be created inside the device so that a fine particle dose is generated from the formulatio...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1053/rmed.2003.1351

    authors: Chrystyn H

    更新日期:2003-02-01 00:00:00

  • Restless legs syndrome: A new comorbidity in idiopathic pulmonary fibrosis.

    abstract:OBJECTIVE:Sleep disorders have a high prevalence among patients with idiopathic pulmonary fibrosis (IPF). The prevalence of restless legs syndrome (RLS) is not known in these patients, neither is its clinical impact as a comorbidity. We investigated the association of RLS with IPF and characterized the clinical feature...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2020.105982

    authors: Varone F,Friello L,Di Blasi C,Sgalla G,Luigetti M,Iovene B,Richeldi L,Della Marca G,Brunetti V

    更新日期:2020-01-01 00:00:00

  • The impact of carrying supplemental oxygen on exercise capacity and dyspnea in patients with interstitial lung disease.

    abstract:BACKGROUND:May patients with interstitial lung disease (ILD) require supplementary oxygen (O2) therapy to maintain normoxia. However, ambulatory O2 delivery devices are constraining and cumbersome. The physiologic and symptomatic impact of these devices on ILD patients is unknown. METHODS:We conducted a prospective st...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2018.03.025

    authors: Ramadurai D,Riordan M,Graney B,Churney T,Olson AL,Swigris JJ

    更新日期:2018-05-01 00:00:00

  • Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

    abstract:OBJECTIVES:To determine the efficacy of oral theophylline compared with placebo in people with stable chronic obstructive pulmonary disease (COPD). METHODS:Systematic review of randomized-controlled trials comparing oral theophylline with placebo for a minimum of 7 days in people with stable COPD. RESULTS:Twenty rand...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.rmed.2004.10.009

    authors: Ram FS,Jardin JR,Atallah A,Castro AA,Mazzini R,Goldstein R,Lacasse Y,Cendon S

    更新日期:2005-02-01 00:00:00

  • Airway inflammation in patients affected by obstructive sleep apnea syndrome.

    abstract::Obstructive sleep apnea syndrome (OSAS) has been shown to be associated to upper airway inflammation. The object of the present study was to establish the presence of bronchial inflammation in OSAS subjects. In 16 subjects affected by OSAS, and in 14 healthy volunteers, airway inflammation was detected by the cellular...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2003.08.003

    authors: Salerno FG,Carpagnano E,Guido P,Bonsignore MR,Roberti A,Aliani M,Vignola AM,Spanevello A

    更新日期:2004-01-01 00:00:00

  • Emerging role of long noncoding RNAs in lung cancer: Current status and future prospects.

    abstract::Lung cancer is the leading cause of cancer-related death worldwide with a 5-year survival rate of less than 15%, despite significant advances in both diagnostic and therapeutic approaches. Combined genomic and transcriptomic sequencing studies have identified numerous genetic driver mutations that are responsible for ...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.rmed.2015.10.006

    authors: Tao H,Yang JJ,Zhou X,Deng ZY,Shi KH,Li J

    更新日期:2016-01-01 00:00:00

  • The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review.

    abstract::Smoking cessation is the most effective way to reduce the risk of developing chronic obstructive pulmonary disease (COPD). It prevents or delays the development of airflow limitation and also reduces its progression. The objective of this study was to systematically review the effects of interventions for smoking cess...

    journal_title:Respiratory medicine

    pub_type: 杂志文章,评审

    doi:10.1016/j.rmed.2004.06.001

    authors: Wagena EJ,van der Meer RM,Ostelo RJ,Jacobs JE,van Schayck CP

    更新日期:2004-09-01 00:00:00

  • Variation in lung cancer survival rates between countries: do differences in data reporting contribute?

    abstract:BACKGROUND:Mortality rates from lung cancer are known to vary considerably between countries. Differences in patients, disease, investigation and treatment are thought to account for some survival shortfalls but it is not known whether differences in collection or processing of data also contribute. METHODOLOGY:We sea...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2005.12.006

    authors: Butler CA,Darragh KM,Currie GP,Anderson WJ

    更新日期:2006-09-01 00:00:00

  • Long-term experience after transition from parenteral prostanoids to oral agents in patients with pulmonary hypertension.

    abstract:BACKGROUND:Long-term follow-up after transition to oral agents from parenteral prostanoid therapy has not been well characterized. METHODS:We reviewed our long-term experience after oral transitioning in patients with pulmonary hypertension. Patients were weaned off parenteral therapy based on a pre-determined outpati...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2007.12.020

    authors: Diaz-Guzman E,Heresi GA,Dweik RA,Minai OA

    更新日期:2008-05-01 00:00:00

  • Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.

    abstract:STUDY OBJECTIVES:Community-acquired pneumonia is a frequent event in the course of chronic obstructive pulmonary disease (COPD). The aim of the present study was to provide information on clinical and microbiological characteristics and outcome of community-acquired pneumonia in these patients, in a comparative study w...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/j.rmed.2007.05.011

    authors: Pifarre R,Falguera M,Vicente-de-Vera C,Nogues A

    更新日期:2007-10-01 00:00:00

  • Serum and pleural fluid levels of CA50 in malignant and tuberculous effusions.

    abstract::The measurement of CA50 in serum and pleural fluid by immunoradiometric assay was presented in 45 (27 malignancy and 18 tuberculosis) patients with pleural effusion. The mean CA50 level in malignant effusion (89.26 +/- 122.32 U ml-1) was significantly higher than that in tuberculous effusion (5.18 +/- 8.65 U ml-1) (P ...

    journal_title:Respiratory medicine

    pub_type: 杂志文章

    doi:10.1016/0954-6111(94)90170-8

    authors: Yang SZ,Ji SQ

    更新日期:1994-01-01 00:00:00